TenSixty Bio
PrivateLast Round
Seed
Aug 24, 2022
Total Funding Raised
$7.2M
Company Overview
TenSixty Bio is a biotechnology company that develops an epitope discovery platform to advance the development of antibody therapeutics for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TenSixty Bio Comparables
Compare TenSixty Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stipple Bio | 78% | |
| Alithea Biotechnology GmbH | 77% | |
| LabGenius Therapeutics | 75% | |
TenSixty Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 24, 2022 |
TenSixty Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Engine | Seed |
| General Catalyst | Seed |
| Wing Venture Capital | Seed |
| Civilization Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2022
$7.2M round led by Venture Highway.
TenSixty Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TenSixty Bio's valuation, stock price, and market status.